Phase I Trial of PX-478
- First Posted Date
- 2007-08-30
- Last Posted Date
- 2018-05-17
- Lead Sponsor
- Cascadian Therapeutics Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT00522652
- Locations
- ๐บ๐ธ
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
๐บ๐ธTGen Clinical Research Services at Scottsdale Healthcare, Scottsdale, Arizona, United States
Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer
- First Posted Date
- 2007-01-01
- Last Posted Date
- 2018-05-16
- Lead Sponsor
- Cascadian Therapeutics Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT00417287
- Locations
- ๐บ๐ธ
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
๐บ๐ธArizona Cancer Center, University of Arizona, Tucson, Arizona, United States
๐บ๐ธTGen Clinical Research Services at Scottsdale Healthcare, Scottsdale, Arizona, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath